BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 21422725)

  • 1. Pathophysiological response to hypoxia - from the molecular mechanisms of malady to drug discovery: drug discovery for targeting the tumor microenvironment.
    Nagasawa H
    J Pharmacol Sci; 2011; 115(4):446-52. PubMed ID: 21422725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiological response to hypoxia - from the molecular mechanisms of malady to drug discovery:hypoxia-inducible factor-1 (HIF-1)-active cells as a target for cancer therapy.
    Kizaka-Kondoh S; Kuchimaru T; Kadonosono T
    J Pharmacol Sci; 2011; 115(4):440-5. PubMed ID: 21422727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-directed drug strategies to target the tumor microenvironment.
    Hay MP; Hicks KO; Wang J
    Adv Exp Med Biol; 2014; 772():111-45. PubMed ID: 24272357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of hypoxia-targeting drugs as new cancer chemotherapeutics.
    Nagasawa H; Uto Y; Kirk KL; Hori H
    Biol Pharm Bull; 2006 Dec; 29(12):2335-42. PubMed ID: 17142959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.
    Xia Y; Choi HK; Lee K
    Eur J Med Chem; 2012 Mar; 49():24-40. PubMed ID: 22305612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiological response to hypoxia - from the molecular mechanisms of malady to drug discovery: epigenetic regulation of the hypoxic response via hypoxia-inducible factor and histone modifying enzymes.
    Mimura I; Tanaka T; Wada Y; Kodama T; Nangaku M
    J Pharmacol Sci; 2011; 115(4):453-8. PubMed ID: 21422728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell physiology regulation by hypoxia inducible factor-1: Targeting oxygen-related nanomachineries of hypoxic cells.
    Eskandani M; Vandghanooni S; Barar J; Nazemiyeh H; Omidi Y
    Int J Biol Macromol; 2017 Jun; 99():46-62. PubMed ID: 28223135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of HIF-1 inhibitors for cancer therapy.
    Onnis B; Rapisarda A; Melillo G
    J Cell Mol Med; 2009 Sep; 13(9A):2780-6. PubMed ID: 19674190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting hypoxia for sensitization of tumors to radio- and chemotherapy.
    Ghattass K; Assah R; El-Sabban M; Gali-Muhtasib H
    Curr Cancer Drug Targets; 2013 Jul; 13(6):670-85. PubMed ID: 23687923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia Induced ER Stress Response as an Adaptive Mechanism in Cancer.
    Chipurupalli S; Kannan E; Tergaonkar V; D'Andrea R; Robinson N
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30754624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The intriguing interplay between therapies targeting the epidermal growth factor receptor, the hypoxic microenvironment and hypoxia-inducible factors.
    Wouters A; Boeckx C; Vermorken JB; Van den Weyngaert D; Peeters M; Lardon F
    Curr Pharm Des; 2013; 19(5):907-17. PubMed ID: 22973959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-Induced Signaling Promotes Prostate Cancer Progression: Exosomes Role as Messenger of Hypoxic Response in Tumor Microenvironment.
    Deep G; Panigrahi GK
    Crit Rev Oncog; 2015; 20(5-6):419-34. PubMed ID: 27279239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia inducible factor in hepatocellular carcinoma: A therapeutic target.
    Lin D; Wu J
    World J Gastroenterol; 2015 Nov; 21(42):12171-8. PubMed ID: 26576101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Research progress of hypoxia-inducible factor 1 inhibitors against tumors].
    Niu F; Li Y; Lai FF; Chen XG
    Yao Xue Xue Bao; 2014 Jun; 49(6):832-6. PubMed ID: 25212028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-inducible factor-1 in human breast and prostate cancer.
    Kimbro KS; Simons JW
    Endocr Relat Cancer; 2006 Sep; 13(3):739-49. PubMed ID: 16954428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular redox status regulates hypoxia inducible factor-1 activity. Role in tumour development.
    Martínez-Sánchez G; Giuliani A
    J Exp Clin Cancer Res; 2007 Mar; 26(1):39-50. PubMed ID: 17550131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances In Developing Novel Anti-Cancer Drugs Targeting Tumor Hypoxic and Acidic Microenvironments.
    Li W; Sun X
    Recent Pat Anticancer Drug Discov; 2018; 13(4):455-468. PubMed ID: 30173649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxic Microenvironment and Metastatic Bone Disease.
    Hiraga T
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30423905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of hypoxia in the hallmarks of human cancer.
    Ruan K; Song G; Ouyang G
    J Cell Biochem; 2009 Aug; 107(6):1053-62. PubMed ID: 19479945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.